trending Market Intelligence /marketintelligence/en/news-insights/trending/8yyHRIUGFU1nvedVDDgaQA2 content esgSubNav
In This List

Galmed Pharmaceuticals launches $35M offering of ordinary shares

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Galmed Pharmaceuticals launches $35M offering of ordinary shares

Galmed Pharmaceuticals Ltd. plans to sell up to $35.0 million of its ordinary shares in an at-the-market equity offering from time to time.

Stifel Nicolaus & Co. Inc. is acting as the sales agent for the offering.